Nearly all early stage business plans have some form of exponential or hockey stick shaped growth plan. Whether an early stage company or an established enterprise, how does an investor or company executive know whether that growth plan is outrageous hyperbole or representative of the opportunity and worthy of increased investment? There are two important […]
Improving Quality or Reducing Cost for On-Market Products
Reducing raw material costs, or investigating ways to scale up component manufacturing processes, are two classic approaches manufacturers focus on to drive down the cost of goods. In addition, there are other areas to consider for improving quality or reducing cost for established products through examination of their standard operating procedures. This is where we […]
De-Risking Adoption of Innovations: Market Risk
In the life sciences, the value of any asset under development (e.g., novel therapeutic, diagnostic, platform technology, or health analytics software) will be mainly a function of risk – because cash flows from successful products can be fairly well benchmarked for a given category [1]. As an investor, entrepreneur, or manager in a growth-stage venture, […]
Managing Market Development: Identifying Critical To Value for a New Product Introduction
Time is money. Wasted time is wasted money. It is critical for today’s Life Science and In-Vitro Diagnostics (IVD) companies to get to market fast and to differentiate themselves from the competition. The pace of innovation in these markets has accelerated and companies now more than ever have difficulty meeting market demands in a timely […]
No-Nonsense Strategic Planning: Make It Meaningful and Actionable
It’s that time of the year again. Time to dust off the desk and put together the business strategy for 2017. How many of you are working at companies that develop a 100-page 3 or 5-year strategic plan that represents a future nirvana vision for your business? The end product is a glorious dream of […]